3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Filgrastim
14
Cyclophosphamide
13
Carboplatin
12
Paclitaxel
8
Ifosfamide
8
Doxorubicin
8
pembrolizumab
7
Peripheral Blood Stem Cell Transplantation
6
Gemcitabine
6
fludarabine
5
Temozolomide
5
Specimen Handling
5
Radiotherapy
5
Cisplatin
5
Magnetic Resonance Spectroscopy
4
Etoposide
4
Docetaxel
4
Amifostine
4
aldesleukin
3
Trastuzumab
3
Taxes
3
Psychiatric Rehabilitation
3
Melphalan
3
Fulvestrant
3
Bevacizumab
3
sodium thiosulfate
2
pazopanib
2
pamiparib
2
palbociclib
2
etoposide phosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Referral and Consultation
×
Sarcoma
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts